Business Description
IntelliPharmaCeutics International Inc
NAICS : 325410
SIC : 3741
ISIN : CA4581731011
Description
IntelliPharmaCeutics International Inc is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IPCIQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.905 | ||
| EPS (TTM) ($) | -0.092 | ||
| Beta | 0.9538 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 1.79 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.15 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.15 - 0.15 | ||
| Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IntelliPharmaCeutics International Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2018-09-14 | 3.43 (-1.86%) | ||
| 0.066:1 Stock Split | 2009-10-22 | 40.00 (-2.22%) | ||
| 0.1:1 Stock Split | 2007-04-17 | 575.76 (-9.52%) |
Show
Entries
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(IPCIQ)'s stock price today?
The current price of IPCIQ is $0.15. The 52 week high of IPCIQ is $0.15 and 52 week low is $0.15.
When is next earnings date of IntelliPharmaCeutics International Inc(IPCIQ)?
The next earnings date of IntelliPharmaCeutics International Inc(IPCIQ) is .
Does IntelliPharmaCeutics International Inc(IPCIQ) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(IPCIQ) does not pay dividend.
Press Release
Articles on IntelliPharmaCeutics International Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers